Biokapital- R&D
     
08.06.10

Maximizing the commercial value of selected biotechnology companies

BioKapital AS is founded to maximize the commercial value of a selected portfolio of biotech companies. BioKapital is owned by Geno SA.

 

This will be achieved through:

  • Active ownership
  • Fundraising
  • R&D expertise
  • IP management
  • Commercialization experience
  • Relevant industrial experience

The markets targeted by the portfolio companies are global agribusiness and aquaculture. The common business idea of the portfolio companies is

 

"Improved efficiency in the food value chain

through application of novel biotechnological inventions"

 

BioKapital AS provides R&D expertise related to artificial insemination (AI) and fertility in domestic animals, gender selection, gene interactions and storage of biological material. The portfolio will be expanded and developed on this basis.

 

Current ownership structure :

 

Ownership structure

 

 

 

 

Print RSS
      | More
BioKapital AS, Holsetgata 22, N-2317 Hamar, Norway Phone: +47 950 20 600 Fax: +47 62 52 06 01
E-mail: post@biokapital.no
VAT Reg. 993130532
 
Infoboks